Challenges in IBD Research 2024: Preclinical Human IBD Mechanisms
Matthew A. Ciorba, Wendy S. Garrett(Harvard University), Elena M. Lucchetta(Leona M. and Harry B. Helmsley Charitable Trust), Andres Hurtado‐Lorenzo(Crohn's and Colitis Foundation), Kristen Johnson(Scripps Research Institute), Liza Konnikova(Yale University), Theresa T. Pizarro(Case Western Reserve University), Alan C. Moss(Action Against Medical Accidents), Anthony Slavin(Woomera Therapeutics), Jerrold R. Turner(Brigham and Women's Hospital), Brandon K Cressall(Crohn's and Colitis Foundation), Cass D Condray(Crohn's and Colitis Foundation), Sungmo Hong(Crohn's and Colitis Foundation), Simon A. Hirota(University of Calgary), Caren Heller(Crohn's and Colitis Foundation), Jennifer L. Swantek(Crohn's and Colitis Foundation)
Cited by 43
Related Papers
Metagenomic biomarker discovery and explanation
|Genome biology|2011|16.7k
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T <sub>reg</sub> Cell Homeostasis
|Science|2013|5.3k
Host microbiota constantly control maturation and function of microglia in the CNS
|Nature Neuroscience|2015|3.4k
Gut microbiota, metabolites and host immunity
|Nature reviews. Immunology|2016|3.3k
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k